FI890393A0 - Foerfarande foer framstaellning av isokinoliner. - Google Patents

Foerfarande foer framstaellning av isokinoliner.

Info

Publication number
FI890393A0
FI890393A0 FI890393A FI890393A FI890393A0 FI 890393 A0 FI890393 A0 FI 890393A0 FI 890393 A FI890393 A FI 890393A FI 890393 A FI890393 A FI 890393A FI 890393 A0 FI890393 A0 FI 890393A0
Authority
FI
Finland
Prior art keywords
frequency
isokinoliner
repair
frequency repair
frequency frequency
Prior art date
Application number
FI890393A
Other languages
English (en)
Other versions
FI890393A (fi
Inventor
Michael John Ashton
Andrew William Bridge
Robert Keith Chambers
Donald Ian Dron
Garry Fenton
Neil Victor Harris
David John Lythgoe
Ian Michael Mcfarlane
Christopher Gregory Newton
David Riddell
Christopher Smith
Keith Alfred James Stuttle
Malcolm Percy Toft
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888801772A external-priority patent/GB8801772D0/en
Priority claimed from GB888819221A external-priority patent/GB8819221D0/en
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of FI890393A0 publication Critical patent/FI890393A0/fi
Publication of FI890393A publication Critical patent/FI890393A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI890393A 1988-01-27 1989-01-26 Foerfarande foer framstaellning av isokinoliner. FI890393A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888801772A GB8801772D0 (en) 1988-01-27 1988-01-27 Compositions of matter
GB888819221A GB8819221D0 (en) 1988-08-12 1988-08-12 New compositions of matter

Publications (2)

Publication Number Publication Date
FI890393A0 true FI890393A0 (fi) 1989-01-26
FI890393A FI890393A (fi) 1989-07-28

Family

ID=26293372

Family Applications (1)

Application Number Title Priority Date Filing Date
FI890393A FI890393A (fi) 1988-01-27 1989-01-26 Foerfarande foer framstaellning av isokinoliner.

Country Status (11)

Country Link
US (1) US5004747A (fi)
EP (1) EP0326386A3 (fi)
JP (1) JPH01242570A (fi)
KR (1) KR890011876A (fi)
AU (1) AU2888289A (fi)
DK (1) DK33789A (fi)
FI (1) FI890393A (fi)
HU (1) HU202842B (fi)
NZ (1) NZ227743A (fi)
OA (1) OA09228A (fi)
PT (1) PT89545B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0424929A1 (en) * 1989-10-27 1991-05-02 Takeda Chemical Industries, Ltd. Isoquinolone derivatives, their production and use
CA2073246A1 (en) * 1990-01-08 1991-07-09 Stanley F. Clark Pyran derivatives
ATE124408T1 (de) * 1990-10-16 1995-07-15 Takeda Chemical Industries Ltd Heterozyklische aminderivate, deren herstellung und deren verwendung.
US5162340A (en) * 1991-05-10 1992-11-10 Merck & Co., Inc. Substituted 1-(2h)-isoquinolinones bearing acidic functional groups as angiotensin ii antagonists
US5260316A (en) * 1991-07-30 1993-11-09 Ciba-Geigy Corporation Isoquinolyl substituted hydroxylamine derivatives
US5350761A (en) * 1991-07-30 1994-09-27 Ciba-Geigy Corporation Indolyl substituted hydroxylamine derivatives
US5334600A (en) * 1991-07-30 1994-08-02 Ciba-Geigy Corporation Isoquinolyl substituted hydroxylamine derivatives
JP3141051B2 (ja) * 1992-10-09 2001-03-05 日清製粉株式会社 抗動脈硬化剤
DE4243279A1 (de) * 1992-12-21 1994-06-23 Bayer Ag Substituierte Triole
EP0634402A1 (en) * 1993-07-14 1995-01-18 Takeda Chemical Industries, Ltd. Isochinolinone derivatives, their production and use
US6083497A (en) 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
GB0003305D0 (en) 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
US7709476B2 (en) * 2003-09-23 2010-05-04 Merck Sharp & Dohme Corp. Isoquinolinone potassium channel inhibitors
PE20060285A1 (es) * 2004-03-30 2006-05-08 Aventis Pharma Inc Piridonas sustituidas como inhibidores de pol(adp-ribosa)-polimerasa (parp)
US9604931B2 (en) 2007-01-22 2017-03-28 Gtx, Inc. Nuclear receptor binding agents
US9623021B2 (en) 2007-01-22 2017-04-18 Gtx, Inc. Nuclear receptor binding agents
CA2676066C (en) 2007-01-22 2016-06-28 Gtx, Inc. Nuclear receptor binding agents
CA2732757A1 (en) * 2008-08-06 2010-02-11 Merck Sharp & Dohme Corp. Substituted dihydroisoquinolinone and isoquinolinedione derivatives as calcium channel blockers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2098980B (en) * 1981-03-28 1985-05-15 Taiho Pharmaceutical Co Ltd 1(2h)-isoquinolone compounds and acid addition salts thereof
AU570021B2 (en) * 1982-11-22 1988-03-03 Novartis Ag Analogs of mevalolactone
US4647576A (en) * 1984-09-24 1987-03-03 Warner-Lambert Company Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis

Also Published As

Publication number Publication date
JPH01242570A (ja) 1989-09-27
KR890011876A (ko) 1989-08-23
AU2888289A (en) 1989-07-27
FI890393A (fi) 1989-07-28
EP0326386A2 (en) 1989-08-02
DK33789A (da) 1989-07-28
PT89545B (pt) 1994-02-28
OA09228A (en) 1992-06-30
US5004747A (en) 1991-04-02
DK33789D0 (da) 1989-01-26
EP0326386A3 (en) 1990-04-25
PT89545A (pt) 1989-10-04
HU202842B (en) 1991-04-29
HUT50783A (en) 1990-03-28
NZ227743A (en) 1991-01-29

Similar Documents

Publication Publication Date Title
DE68916889T2 (de) Frequenzsynthesierer.
FI900147A0 (fi) Daempningsanordning foer stoetbelastning.
FI890393A0 (fi) Foerfarande foer framstaellning av isokinoliner.
DE68921897T2 (de) Hochfrequenz-Heizapparat.
NO904210D0 (no) Syntese av hydrokarbylaminer.
DE68912635D1 (de) Frequenzzähler.
FI896343A0 (fi) Mikrocellskum med slutna celler och foerfarande foer framstaellning av dessa.
NO890483L (no) Framgangsmaate for tilvirkning av formlegemer.
FI882265A0 (fi) Foerfarande foer bestaemning av fruktosamin.
FI894427A (fi) Digital frekvensgenerator.
DE68909453D1 (de) Frequenzbestimmung.
ATE125794T1 (de) Prodrogen von antiinflammatorischen 3-acyl-2- oxindol-1-carboxamiden.
DE58907950D1 (de) Frequenzsynthesegerät.
NO893890L (no) Fremgangsmaate for fjerning av sulfider.
DE68906482D1 (de) Frequenz-wandler.
FI901191A0 (fi) Foerfarande foer styrd foeraendring av en gen.
DE68917081D1 (de) Hochfrequenz-Oszillator.
DE69002136D1 (de) Saccharidderivate von protocatechualdehyd.
FI891897A0 (fi) Synkronisering av en frekvensklocka.
DE3885954T2 (de) Hochfrequenzgenerator.
FI920227A0 (fi) Foerfarande foer framstaellning av 4-demetoxi-4-aminoantracykliner.
RO96431A2 (ro) Freza radiala
FI906144A0 (fi) Modifiering av plasminogenaktivatorer.
FI904082A0 (fi) Foerfarande foer framstaellning av n-heterocyklyl-4-piperidinaminer.
NO911673D0 (no) Filament - hemagglutinin av b. pertussis.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: MAY & BAKER LIMITED